The IL-36γ-mediated anti-tumorigenic response was characterised by a reduction in tumour-promoting B cells, a reduction in Gr1+ neutrophilic MDSCs, enhanced expression of MHC class II molecules across all MDSC subsets, and increased infiltration of CD8+ lymphocytes and NK cells into the tumours. Here, IL36G is linked to neoplasm.